Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP

Abdulwahid, D.; Arbuthnot, C.; Paneesha, S.; Jobanputra, S.; Borg, A.

Author

Abdulwahid, D.
Arbuthnot, C.
Paneesha, S.
Jobanputra, S.
Borg, A.

Affiliation

University Hospitals Coventry and Warwickshire NHS Trust; South Warwickshire University NHS Foundation Trust; Heart of England Foundation NHS Trust, Birmingham

Publication date

2016-04-12

Subject

Haematology
Oncology. Pathology.

Metadata

Show full item record

Abstract

Poster abstract 198 in the section 'Lymphoid Malignancy – Clinical' of the XXXVI World Congress of the International Society of Hematology, hosted by the British Society for Haematology, 18–21 April 2016, Glasgow, UK.

Citation

Abdulwahid D, Arbuthnot C, Paneesha S, Jobanputra S, Borg A. Efficacy and safety of RCEOP chemotherapy in patients with diffuse large cell lymphoma (DLCL) not fit for anthracyclines are comparable to RCHOP. Br J Haematol. 2016 Apr;173(Suppl 1):83. doi: 10.1111/bjh.14019.

Type

Conference Output